title: Prolonged cellular midostaurin retention suggests potential alternative dosing strategies for FLT3-ITD-positive leukemias.
authors.affiliation: Department of Hematology and Oncology, Medical Center, Otto-von-Guericke-University, Magdeburg, Germany.
authors.forename: D B
authors.initials: DB
authors.lastname: Lipka
authors.affiliation: Department of Hematology and Oncology, Medical Center, Otto-von-Guericke-University, Magdeburg, Germany.
authors.forename: M-C
authors.initials: MC
authors.lastname: Wagner
authors.affiliation: Institute of Forensic Medicine, Medical Center, Otto-von-Guericke-University, Magdeburg, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Dziadosz
authors.affiliation: Department of Hematology and Oncology, Medical Center, Otto-von-Guericke-University, Magdeburg, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Fischer
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003470:Culture Media; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D051379:Mice; D019311:Staurosporine / Q000031:analogs & derivatives* / Q000378:metabolism; D051941:fms-Like Tyrosine Kinase 3 / Q000235:genetics*
chemical_list: D000970:Antineoplastic Agents; D003470:Culture Media; C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3; D019311:Staurosporine; C059539:midostaurin